SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-150268
Filing Date
2020-05-22
Accepted
2020-05-22 17:07:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424(B)(5) d901687d424b5.htm 424B5 147527
2 GRAPHIC g901687g07e55.jpg GRAPHIC 39955
  Complete submission text file 0001193125-20-150268.txt   199468
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238128 | Film No.: 20906901
SIC: 2834 Pharmaceutical Preparations